Newark Beth Israel Medical Center, previously Newark Beth Israel Hospital, is a 665-bed quaternary care, teaching hospital located in Newark, New Jersey serving the healthcare needs for Newark and the Northern Jersey area.

There are 665 beds in Rutgers Cancer Institute of New Jersey,201 Lyons Avenue.

During the past decade, Rutgers Cancer Institute of New Jersey,201 Lyons Avenue conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rutgers Cancer Institute of New Jersey,201 Lyons Avenue" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rutgers Cancer Institute of New Jersey,201 Lyons Avenue" are "Triple Negative Breast Cancer" (2 trials), "PD-L1 Negative" (1 trials) and "PD-L1 Positive" (1 trials). Many other conditions were trialed in "Rutgers Cancer Institute of New Jersey,201 Lyons Avenue" in a lesser frequency.

Most popular intervention types in "Rutgers Cancer Institute of New Jersey,201 Lyons Avenue" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "Paclitaxel" (2 trials), "Sacituzumab Govitecan-hziy" (2 trials) and "nab-Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rutgers Cancer Institute of New Jersey,201 Lyons Avenue" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Rutgers Cancer Institute of New Jersey,201 Lyons Avenue". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Rutgers Cancer Institute of New Jersey,201 Lyons Avenue, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rutgers Cancer Institute of New Jersey,201 Lyons Avenue, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".